Now a Nobel gas: oxygen

被引：46

作者：

Fandrey, Joachim ^{[1
]}

Schoedel, Johannes ^{[2
]}

Eckardt, Kai-Uwe ^{[3
]}

Katschinski, Doerthe M. ^{[4
]}

Wenger, Roland H. ^{[5
,6
]}

机构：

[1] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany

[2] Friedrich Alexander Univ Erlangen Nuremberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany

[3] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, D-10117 Berlin, Germany

[4] Georg August Univ, Inst Cardiovasc Physiol, Univ Med Ctr Gottingen, D-37073 Gottingen, Germany

[5] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland

[6] Univ Zurich, Natl Ctr Competence Res Kidney CH, CH-8057 Zurich, Switzerland

来源：

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2019年 / 471卷 / 11-12期

基金：

瑞士国家科学基金会;

关键词：

Erythropoietin; High altitude; Hypoxia; Oxygen sensing; Protein hydroxylation; von Hippel-Lindau; HYPOXIA-INDUCIBLE FACTOR-1; HUMAN ERYTHROPOIETIN GENE; ENDOTHELIAL GROWTH-FACTOR; FACTOR PROLYL HYDROXYLASE; TUMOR-SUPPRESSOR PROTEIN; GENOME-WIDE IDENTIFICATION; CHRONIC KIDNEY-DISEASE; RENAL-CELL CARCINOMA; HIF-BINDING SITES; TRANSGENIC MICE;

D O I：

10.1007/s00424-019-02334-8

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

The recent bestowal of the Nobel Prize 2019 in Physiology or Medicine to Gregg L. Semenza, Sir Peter J. Ratcliffe, and William G. Kaelin Jr. celebrates a series of remarkable discoveries that span from the physiological research question on how oxygen deficiency (hypoxia) induces the red blood cell forming hormone erythropoietin (Epo) to the first clinical application of a novel family of Epo-inducing drugs to treat patients suffering from renal anemia. This review looks back at the most important findings made by the three Nobel laureates, highlights current research trends, and sheds an eye on future perspectives of hypoxia research, including emerging and potential clinical applications.

引用

页码：1343 / 1358

页数：16

共 161 条

[1] Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor [J].

Adams, David F. ;

Watkins, Mark S. ;

Durette, Luc ;

Laliberte, Josee ;

Goulet, Felix ;

Debien, Elaine ;

Frazier, Kendall S. ;

Mellal, Nacera ;

Chen, Liangfu ;

Shi, Wei ;

Thomas, Roberta ;

Hu, Erding .

TOXICOLOGIC PATHOLOGY, 2020, 48 (02) :362-378

[2]

Aei K, 2012, KIDNEY INT, V2, P279

[3] Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994) [J].

Astor, BC ;

Muntner, P ;

Levin, A ;

Eustace, JA ;

Coresh, J .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) :1401-1408

[4] Mechanisms of Anemia in CKD [J].

Babitt, Jodie L. ;

Lin, Herbert Y. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10) :1631-1634

[5] Hypoxia induces rapid changes to histone methylation and reprograms chromatin [J].

Batie, Michael ;

Frost, Julianty ;

Frost, Mark ;

Wilson, James W. ;

Schofield, Pieta ;

Rocha, Sonia .

SCIENCE, 2019, 363 (6432) :1222-+

[6] Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats [J].

Beck, James ;

Henschel, Carroll ;

Chou, James ;

Lin, Al ;

del Balzo, Ughetta .

INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (06) :427-439

[7] Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide [J].

Berchner-Pfannschmidt, Utta ;

Tug, Suzan ;

Trinidad, Buena ;

Oehme, Felix ;

Yamac, Hatice ;

Wotzlaw, Christoph ;

Flamme, Ingo ;

Fandrey, Joachim .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) :31745-31753

[8] Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model [J].

Bernhardt, W. M. ;

Gottmann, U. ;

Doyon, F. ;

Buchholz, B. ;

Campean, V. ;

Schoedel, J. ;

Reisenbuechler, A. ;

Klaus, S. ;

Arend, M. ;

Flippin, L. ;

Willam, C. ;

Wiesener, M. S. ;

Yard, B. ;

Warnecke, C. ;

Eckardt, K. -U. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (50) :21276-21281

[9] Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD [J].

Bernhardt, Wanja M. ;

Wiesener, Michael S. ;

Scigalla, Paul ;

Chou, James ;

Schmieder, Roland E. ;

Guenzler, Volkmar ;

Eckardt, Kai-Uwe .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (12) :2151-2156

[10] HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine [J].

Bishop, Tammie ;

Ratcliffe, Peter J. .

CIRCULATION RESEARCH, 2015, 117 (01) :65-79

← 1 2 3 4 5 6 7 8 9 10 →